Central Nervous System White Papers & Case Studies

1. SynteractHCR Full-Service CRO Brochure 3/4/2016

   SynteractHCR is a multinational clinical research organization, formed from the merger of Synteract with Harrison Clinical Research in 2013, which provides global, full-service clinical trial services. We have more than two decades of experience supporting biopharma companies in all phases of clinical development across multiple therapeutic areas. We customize programs that will deliver timely, high quality data to help you get to decision points faster, taking time and cost out of drug development.

2. Improve Accuracy And Efficiency In Data Collection For Mental-Health Evaluations And Assessments 5/29/2013

   MedAvante is a global provider of centralized, expert psychological rating services to the pharmaceutical, biotechnology, and medical device industries.

3. Phase II Alzheimer's Case Study 5/29/2013

   A double-blind, Phase II, placebo-controlled clinical trial to evaluate the safety and efficacy of a novel compound in subjects with mild to moderate Alzheimer’s disease.

4. Moving Towards An Electronic Environment In Clinical Trials 5/3/2013

   With each passing year, clinical trials are becoming increasingly global. The business of product development is moving away from the traditional model in which studies are conducted primarily in the US – in fact, recent estimates indicate that within the next three years, up to 65 per cent of studies under FDA regulation will be conducted outside the US. A review of a US government clinical trials registry and of 300 published reports in major medical journals revealed that one third (157 of 509) of Phase III trials were being conducted entirely outside the US, with over half the study sites (13,521 of 24,206) used in these trials located overseas, many in eastern Europe and Asia.

5. Brochure: Norwich Clinical Services 2/1/2013

   Norwich Clinical Services is a contract research organization that provides Bioanalytical Services, Pharmacovigilance and Clinical Research Programs to the pharmaceutical and biotech industries.

6. Optimizing Clinical Trial Enrollment: Same Day Turnaround Of Blood Chemistry For Eligibility 5/22/2012

   Potential clinical trial participants and sponsors typically wait 2-3 days for lab results to determine eligibility. For the would-be participant every day that elapses could contribute to the loss of interest and increase the risk of losing a potential study subject for many reasons. By Paul S. Savuto, MS, MBA Blinded Diagnostics

7. Patient Major Depression Disorder Case Study 5/4/2012

   ePharmaSolutions, a global site activation and patient enrollment company developed and deployed a geo-targeted direct-to-patient outreach, education and recruitment campaign to augment enrollment for a Major Depressive Disorder program being conducted at 100 study centers in North America.

8. Therapeutic Expertise: Neuroscience & CNS Datasheet 3/27/2012
   PRA is a leader in the clinical research industry, providing innovative solutions for CNS drug development.
9. CNS Services Brochure 3/15/2012
   A leading western CRO in Russia, ClinStar offers invaluable experience to enhance your study execution, resulting in higher-quality results. We offer local regulatory, customs and logistical expertise as well as clinical teams that are therapeutically trained in CNS diseases.
10. Epilepsy Drug Study: Ambulatory EEG Application For Safety And Efficacy 1/9/2012
    A global leader dedicated to the development and commercialization of pharmaceuticals to treat serious neurological and psychiatric disorders.